Telesis Bio Executives
TBIODelisted Stock | USD 2.98 0.02 0.67% |
Telesis Bio employs about 101 people. The company is managed by 10 executives with a total tenure of roughly 236 years, averaging almost 23.0 years of service per executive, having 10.1 employees per reported executive. Analysis of Telesis Bio's management performance can provide insight into the firm performance.
Eric Esser CEO CEO, President |
Telesis |
Telesis Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.2652) % which means that it has lost $0.2652 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4784) %, meaning that it created substantial loss on money invested by shareholders. Telesis Bio's management efficiency ratios could be used to measure how well Telesis Bio manages its routine affairs as well as how well it operates its assets and liabilities.Telesis Bio Workforce Comparison
Telesis Bio is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 155,584. Telesis Bio adds roughly 101 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (2.53) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (6.76) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $6.76. Telesis Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Telesis Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Telesis Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Telesis Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nachtsheim Jami K over three months ago Acquisition by Nachtsheim Jami K of 70129 shares of Telesis Bio at 1.54 subject to Rule 16b-3 | ||
Weissman James B over six months ago Acquisition by Weissman James B of 5268 shares of Telesis Bio at 4.1 subject to Rule 16b-3 | ||
Weissman James B over six months ago Insider Trading | ||
Witney Frank over six months ago Acquisition by Witney Frank of 48354 shares of Telesis Bio subject to Rule 16b-3 | ||
Herrema Gregory J. over six months ago Acquisition by Herrema Gregory J. of 30362 shares of Telesis Bio at 0.3557 subject to Rule 16b-3 | ||
Cutler Rob over six months ago Acquisition by Cutler Rob of 13800 shares of Telesis Bio subject to Rule 16b-3 | ||
Eric Esser over six months ago Acquisition by Eric Esser of 100000 shares of Telesis Bio subject to Rule 16b-3 | ||
Schroer John R. over six months ago Acquisition by Schroer John R. of 150000 shares of Telesis Bio at 7.66 subject to Rule 16b-3 |
Telesis Bio Notable Stakeholders
A Telesis Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Telesis Bio often face trade-offs trying to please all of them. Telesis Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Telesis Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eric Esser | CEO, President | Profile | |
Richard Lepke | Director Relations | Profile | |
Dr MBA | Founder Director | Profile | |
Decky MBA | Senior Development | Profile | |
Laura MBA | Vice Culture | Profile | |
Jen Carroll | Vice Relations | Profile | |
Laurence Warden | Senior Instrumentation | Profile | |
William Kullback | Chief Officer | Profile | |
Daniel Gibson | Chief Officer | Profile | |
Robert Cutler | Chief Officer | Profile |
About Telesis Bio Management Performance
The success or failure of an entity such as Telesis Bio often depends on how effective the management is. Telesis Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Telesis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Telesis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.
Telesis Bio Workforce Analysis
Traditionally, organizations such as Telesis Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Telesis Bio within its industry.Telesis Bio Manpower Efficiency
Return on Telesis Bio Manpower
Revenue Per Employee | 272.4K | |
Revenue Per Executive | 2.8M | |
Net Loss Per Employee | 472.5K | |
Net Loss Per Executive | 4.8M | |
Working Capital Per Employee | 219.5K | |
Working Capital Per Executive | 2.2M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Telesis Pink Sheet
If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |